Colorectal Cancer: Epidemiology, Risk Factors, and Health Services

ABSTRACT

Colorectal carcinoma is the third most common cancer in the United States in both men and women but still remains the second leading cause of cancer-related deaths. The risk of developing colorectal cancer increases with age. Additional risk factors include family history of colorectal cancer, heredity conditions such as polyposis and hereditary nonpolyposis colorectal cancer, and personal history of inflammatory bowel disease, polyps, and cancers. Health services is a new scientific discipline that examines the quality of care, often at the population level, and may examine parts or the entire spectrum of care.

KEYWORDS

Colorectal cancer - epidemiology - risk factors

REFERENCES

• 1 American Cancer Society .Cancer Facts and Figures 2003. Atlanta, GA; American Cancer Society 2003
• 2 Troisi R J, Freedman A N, Devesa S S. Incidence of colorectal carcinoma in the US: an update of trends by gender, race, age, subsite, and stage, 1975-1994.  Cancer. 1999;  85 1670-1676
• 3 Jemal A, Murray T, Samuels A et al.. Cancer statistics 2003.  CA Cancer J Clin. 2003;  53 5-26
• 4 American Cancer Society .Cancer Facts and Figures 2004. Atlanta, GA; American Cancer Society 2004
• 5 O'Connell J B, Maggard M A, Ko C Y. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging.  J Natl Cancer Inst. 2004;  96 1420-1425
• 6 Greenlee R T, Murray T, Bolden S, Wingo P A. Cancer Statistics 2000.  CA Cancer J Clin. 2000;  50 7-33
• 7 Trowbridge B, Burt R W. Colorectal cancer screening.  Surg Clin North Am. 2002;  82 943-957
• 8 Kemppainen M, Raiha I, Rajala T, Sourander L. Characteristics of colon cancer in elderly patients.  Gerontology. 1993;  39 222-227
• 9 MacGillivray D C, Swart S E, Robinson A M et al.. Adenocarcinoma of the colon and rectum in patients less than 40 years of age.  Surg Gynecol Obstet. 1991;  172 1-7
• 10 Wei E K, Giovannucci E, Wu K et al.. Comparison of risk factors for colon and rectal cancer.  Int J Cancer. 2004;  108 433-442
• 11 McArdle C S, Hole D J. Outcomes following surgery for colorectal cancer.  Br Med Bull. 2002;  64 119-125
• 12 Ghafoor A, Jemal A, Cokkinides V et al.. Cancer statistics for African Americans.  CA Cancer J Clin. 2002;  52 326-341
• 13 Mayberry R M, Coates R J, Hill H A, Click L A. Determinants of black/white differences in colon cancer survival.  J Natl Cancer Inst. 1995;  87 1686-1693
• 14 Parker S L, Davis K J, Wingo P A et al.. Cancer statistics by race and ethnicity.  CA Cancer J Clin. 1998;  48 31-48
• 15 Ries L AG, Eisner M P, Kosary Cl et al.. SEER Cancer Statistics Review, 1975-2000. Bethesda, MD; National Cancer Institute 2003
• 16 Freeman H P, Alshafie T A. Colorectal carcinoma in poor blacks.  Cancer. 2002;  94 2327-2332
• 17 Wudel L J, Chapman W C, Shyr Y et al.. Disparate outcomes in patients with colorectal cancer. Effect of race on long term survival.  Arch Surg. 2002;  137 550-556
• 18 Roetzheim R G, Pal N, Gonzalez E C et al.. Effects of health insurance and race on colorectal cancer treatment and outcomes.  Am J Public Health. 2000;  90 1746-1754
• 19 Hoffman-Goetz L, Breen N L, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States.  Ethn Dis. 1998;  8 43-51
• 20 McMahon Jr L F, Wolfe R A, Huang S et al.. Racial and gender variation in use of diagnostic colonic procedures in the Michigan Medicare population.  Med Care. 1999;  37 712-717
• 21 Shavers V L, Brown M L. Racial and ethnic disparities in the receipt of cancer treatment.  J Natl Cancer Inst. 2002;  94 334-357
• 22 Roetzheim R G, Pal N, Gonzalez E C, Ferrante J M, Van Durme D J, Krischer J P. Effects of health insurance and race on colorectal cancer treatments and outcomes.  Am J Public Health. 2000;  90 1746-1754
• 23 Potosky A L, Harlan L C, Kaplan R S et al.. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer.  J Clin Oncol. 2002;  20 1192-1202
• 24 Rabeneck L, Soucheck J, El-Serag H B. Survival of colorectal cancer patients hospitalized in the VA health care system.  Am J Gastroenterol. 2003;  98 1186-1192
• 25 Rozen P, Fireman Z, Figer A et al.. Family history of colorectal cancer as a marker of potential malignancy within a screening program.  Cancer. 1987;  60 248-254
• 26 Sondergaard J O, Bulow S, Lynge E. Cancer incidence among parents of patients with colorectal cancer.  Cancer. 1991;  47 202-206
• 27 Fuchs C S, Giovannucci E L, Colditz G A et al.. A prospective study of family history and the risk of colorectal cancer.  N Engl J Med. 1994;  331 1669-1674
• 28 St John D JB, McDermott F T, Hopper J L et al.. Cancer risk in relatives of patients with common colorectal cancer.  Ann Intern Med. 1993;  118 785-790
• 29 Lynch H T, de la Chapelle A. Hereditary colorectal cancer.  N Engl J Med. 2003;  348 919-932
• 30 Kinzler K W, Vogelstein B. Landscaping the cancer terrain.  Science. 1998;  280 1036-1037
• 31 Laken S J, Peteren G M, Gruber S B et al.. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.  Nat Genet. 1997;  17 79-83
• 32 Rozen P, Shomrat R, Stul H et al.. Prevalence of the I1307k APC gene variant in Israeli Jews of different ethnic origin and the risk of colorectal cancer.  Gastroenterology. 1999;  116 54-57
• 33 Gryfe R, Di Nocola N, Lal G et al.. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism.  Am J Hum Genet. 1999;  64 378-384
• 34 Woodage T, King S M, Wacholder S et al.. The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews.  Nat Genet. 1998;  20 62-65
• 35 Grady W M, Markowitz S D. Hereditary colon cancer genes.  Methods Mol Biol. 2003;  222 59-83
• 36 Sieber O M, Lipton L, Crabtree M et al.. Multiple colorectal adenomas, classic adenomatous polyposis and germ-line mutations in MYH.  N Engl J Med. 2003;  348 791-799
• 37 Lynch H T, Fitzgibbons R. Surgery, desmoid tumors, and familial adenomatous polyposis: case report and literature review.  Am J Gastroenterol. 1996;  91 2598-2601
• 38 Offerhaus G J, Giardiello F M, Krush A J et al.. The risk of upper gastrointestinal cancer in familial adenomatous polyposis.  Gastroenterology. 1992;  102 1980-1982
• 39 Lynch H T, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review.  Cancer. 1996;  78 1149-1167
• 40 Watson P, Lynch H T. Extracolonic cancer in hereditary nonpolyposis colorectal cancer.  Cancer. 1993;  71 677-685
• 41 Muller A D, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case control study of 32,702 veterans.  Ann Intern Med. 1995;  123 904-910
• 42 Stryker S J, Wolff B G, Culp C E et al.. Natural history of untreated colonic polyps.  Gastroenterology. 1987;  93 1009-1013
• 43 Shinya H, Wolff W I. Morphology, anatomic distribution and cancer potential of colonic polyps.  Ann. Surg. 1979;  190 679-683
• 44 Winawer S J, Stewart E T, Zauber A G et al.. A comparison of colonoscopy and double contrast barium enema for surveillance after polypectomy. National Polyp Study Group.  N Engl J Med. 2000;  342 1766-1772
• 45 Gyde S N, Prior P, Allan R N et al.. Colorectal cancer in ulcerative colitis: a cohort study of primary referrals from three centers.  Gut. 1988;  29 206-217
• 46 Gillen C D, Andrews H A, Prior P, Allan R N. Crohn's disease and colorectal cancer.  Gut. 1994;  35 651-655
• 47 Ekbom A, Helmick C, Zack M, Adami H O. Ulcerative colitis and colorectal cancer. A population based study.  N Engl J Med. 1990;  323 1228-1233
• 48 Lindberg B, Persson B, Veress B, Ingelman-Sundberg H, Grangvist S. Twenty years' colonoscopic surveillance of patients with ulcerative colitis. Detection of dysplastic and malignant transformation.  Scand J Gastroenterol. 1996;  31 1195-1204
• 49 Bernstein C N, Blanchard J F, Kliewer E, Wajda A. Cancer risk in patients with inflammatory bowel disease: a population based study.  Cancer. 2001;  91 854-862
• 50 Bansal P, Sonnenberg A. Risk factors of colorectal cancer in inflammatory bowel disease.  Am J Gastroenterol. 1996;  91 44-48
• 51 Butler L M, Sinha R, Milikan R C et al.. Heterocyclic amines, meat intake, and association with colon cancer in a population-based study.  Am J Epidemiol. 2003;  157 434-445
• 52 Kampman E, Slattery M L, Bigler J et al.. Meat consumption, genetic susceptibility, and colon cancer risk: a United States multicenter case-control study.  Cancer Epidemiol Biomarkers Prev. 1999;  8 15-24
• 53 Fuchs C S, Giovannucci E L, Colditz G A et al.. Dietary fiber and the risk of colorectal cancer and adenoma in women.  N Engl J Med. 1999;  340 169-176
• 54 Pietinen P, Malila N, Virtanen M et al.. Diet and risk of colorectal cancer in a cohort of Finnish men.  Cancer Causes Control. 1999;  10 387-396
• 55 Terry P, Giovannucci E, Michels K B et al.. Fruit, vegetables, dietary fiber, and the risk of colorectal cancer.  J Natl Cancer Inst. 2001;  93 525-533
• 56 Baron J A, Beach M, Mandel J S et al.. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group.  N Engl J Med. 1999;  340 101-107
• 57 Giovannucci E, Colditz G A, Stampfer M J et al.. A prospective study of cigarette smoking and risk of colorectal adenoma and colorectal cancer in U.S. women.  J Natl Cancer Inst. 1994;  86 192-199
• 58 Slattery M L, Potter J D, Friedman G D et al.. Tobacco use and colon cancer.  Int J Cancer. 1997;  70 259-264
• 59 Knekt P, Hakama M, Jarvinen R et al.. Smoking and the risk of colorectal cancer.  Br J Cancer. 1998;  78 136-139
• 60 U.S. Preventive Services Task Force . Screening for colorectal cancer: recommendation and rationale.  Ann Intern Med. 2002;  137 129-131
• 61 Mandel J S, Church T R, Bond J H et al.. The effect of fecal occult-blood screening on the incidence of colorectal cancer.  N Engl J Med. 2000;  343 1603-1607
• 62 Mandel J S, Bond J H, Church T H et al.. Reducing mortality from colorectal cancer by screening for fecal occult blood.  N Engl J Med. 1993;  328 1365-1371
• 63 Mandel J S, Church T R, Ederer F, Bond J H. Colorectal cancer mortality: effectiveness of biennial screening for colorectal cancer.  J Natl Cancer Inst. 1999;  91 434-437
• 64 Centers for Disease Control and Prevention .Colorectal cancer: the importance of prevention and early detection. Atlanta, GA; Centers for Disease Control and Prevention 2003 Available at: http://www.cdc.gov/cancer. Accessed on 12/2/2004
• 65 National Cancer Institute .Cancer Progress Report-2003 Update: Colorectal Cancer Screening. National Cancer Institute 2003 Available at: http://www.progressreport.cancer.gov. Accessed on 12/7/2004
• 66 Etzioni D A, Ponce N A, Babey S H et al.. A population-based study of colorectal cancer test use: results from the 2001 California Health Interview Survey.  Cancer. 2004;  101 2523-2532
• 67 Cokkinides V E, Chao A, Smith R A, Vernon S W, Thun M J. Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older.  Prev Med. 2003;  36 85-91
• 68 Weir H K, Thun M J, Hankey B F et al.. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.  J Natl Cancer Inst. 2003;  95 1276-1299
• 69 Provenzale D, Gray R N. Colorectal cancer screening and treatment: review of outcomes research.  J Natl Cancer Inst Monogr. 2004;  33 45-55
• 70 Sheikh R A, Kapre S, Calof O M, Ward C, Raina A. Screening preferences for colorectal cancer: a patient demographics study.  South Med J. 2004;  97 224-230
• 71 National Cancer Institute .Colon Cancer (PDQ): treatment. National Cancer Institute 2004 Available at: http://www.cancer.gov/cancertopics/pdq/treatment/colon/patient Accessed on 12/10/2004
• 72 National Cancer Institute .Rectal Cancer (PDQ): treatment. National Cancer Institute. 2004 Available at: http://www.cancer.gov/cancertopics/pdq/treatment/rectal/patient. Accessed on 12/10/2004
• 73 Ayanian J Z, Zaslavsky A M, Fuchs C S et al.. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.  J Clin Oncol. 2003;  21 1293-1300
• 74 Baxter N N, Rothenberger D A, Morris A M, Bullard K M. Adjuvant radiation for rectal cancer: do we measure up to the standard of care? An epidemiologic analysis of trends over 25 years in the United States.  Dis Colon Rectum. 2005;  48 9-15
• 75 Govindarajan R, Shah R V, Erkman L G, Hutchins L F. Racial differences in the outcome of patients with colorectal carcinoma.  Cancer. 2003;  97 493-498
• 76 Demissie K, Oluwole O O, Balasubramanian B A et al.. Racial differences in the treatment of colorectal cancer: a comparison of surgical and radiation therapy between whites and blacks.  Ann Epidemiol. 2004;  14 215-221
• 77 Rogers S O, Ray W A, Smalley W E. A population-based study of survival among elderly persons diagnosed with colorectal cancer: does race matter if all are insured? (United States).  Cancer Cases Control. 2004;  15 193-199
• 78 Rabeneck L, Souchek J, El-Serag H B. Survival of colorectal cancer patients hospitalized in the Veterans Affairs Health Care System.  Am J Gastroenterol. 2003;  98 1186-1192